Home
UKMi Information
 Information MI News

UKMi Directory
ukmi Development

consultation

UKMi Pandemic Flu

Welcome to the UK Medicines Information website.

This site is designed to support the UKMi network. It hosts our strategy, policies, clinical governance standards and training materials, together with minutes of meetings of the UKMi Executive and its working groups.

UKMi resources to support medicines management initiatives are hosted by the National electronic Library for Medicines (NeLM).

Resources for the public can be found at NHS Direct.

For UK health professionals, click on the map to search for your local medicines information centre.
dotMedicines evaluation (LCNDG):Pertuzumab with docetaxel and trastuzumab for first-line HER2 positive metastatic or locally recurrent unresectable breast cancer, previously untreated or who have relapsed post adjuvant [LINK] NEW (15/05/2013)
newsline
dotMedicines evaluation (LCNDG): Brentuximab vedotin for systemic anaplastic large cell lymphoma [LINK] NEW (15/05/2013)
newsline
dotMedicines evaluation (LCNDG): Bendamustine with rituximab for relapsed indolent B-cell and mantle cell lymphoma including relapsed/refractoryWaldenstrÖm’s macroglobulinaemia [LINK] NEW (15/05/2013)
newsline
dotMedicines evaluation (LCNDG): Vismodegib for locally advanced or metastatic basal cell carcinoma [LINK] (09/05/2013)
newsline
dotMedicines evaluation (UKMi): Rifaximin for Travellers’ Diarrhoea [LINK] (08/05/2013)
newsline
dotMedicines Q&A: Magnesium preparations for hypomagnesaemia [LINK] (08/05/2013)
newsline
dotMedicines Q&A: Statins in patients with renal impairment [LINK] (08/05/2013)
newsline
dotMedicines Q&A: Oxygen cylinders in nursing homes [LINK] (08/05/2013)
newsline
dotNew Product Evaluations - monthly list April 2013 updates [LINK] (03/05/2013)
newsline
dotMedicines Q&A: Document providing links to UKMi-produced Q&As on Evidence Search, organised by BNF category [LINK] (02/05/2013)
newsline
more >>>